Literature DB >> 15359576

Influence of the type of surfactant and the degree of dispersion on the lymphatic transport of halofantrine in conscious rats.

Ditte M Karpf1, René Holm, Henning G Kristensen, Anette Müllertz.   

Abstract

PURPOSE: To compare the lymphatic transport and the portal absorption of halofantrine (Hf) when administered in (i) a triacylglycerol (TG) solution, (ii) an o/w-emulsion that contains a metabolizable surfactant, and (iii) an o/w-emulsion that contains a synthetic surfactant.
METHODS: Lymph cannulated rats were orally dosed with Hf in a TG solution or in o/w-emulsions dispersed by lecithin or Cremophor RH40. Lymph was continuously collected, and blood was sampled periodically in the course of 30 h. Hf in the lymph and blood and TG and phosphatidyl choline (PC) in the lymph were analyzed.
RESULTS: A significantly (p < 0.05) higher level of Hf was found in the intestinal lymph when dosed in one of the emulsions (22.8+/-2.8% and 20.2+/-2.5%) compared to in the TG solution (7.9+/-1.1%). No difference in the lymphatic transport of Hf was observed between the two emulsions. The portal absorption of Hf was similar for the three vehicles.
CONCLUSIONS: The emulsified vehicles favor an increased lymphatic transport of Hf. The portal transport of Hf was not significantly different for the three vehicles. This indicates that a different degree of dispersion of the TG vehicle can change the route of transportation of Hf.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15359576     DOI: 10.1023/b:pham.0000036915.03725.19

Source DB:  PubMed          Journal:  Pharm Res        ISSN: 0724-8741            Impact factor:   4.200


  26 in total

1.  Effect of bile on absorption of mepitiostane by the lymphatic system in rats.

Authors:  T Ichihashi; H Kinoshita; Y Takagishi; H Yamada
Journal:  J Pharm Pharmacol       Date:  1992-07       Impact factor: 3.765

2.  Lymphatic transport of halofantrine in the triple-cannulated anesthetized rat model: effect of lipid vehicle dispersion.

Authors:  C J Porter; S A Charman; W N Charman
Journal:  J Pharm Sci       Date:  1996-04       Impact factor: 3.534

3.  Enhanced intestinal absorption of cyclosporine in rats through the reduction of emulsion droplet size.

Authors:  B D Tarr; S H Yalkowsky
Journal:  Pharm Res       Date:  1989-01       Impact factor: 4.200

4.  Comparison of the lymphatic transport of halofantrine administered in disperse systems containing three different unsaturated fatty acids.

Authors:  R Holm; A Müllertz; G P Pedersen; H G Kristensen
Journal:  Pharm Res       Date:  2001-09       Impact factor: 4.200

Review 5.  A proposed model for the assembly of chylomicrons.

Authors:  M M Hussain
Journal:  Atherosclerosis       Date:  2000-01       Impact factor: 5.162

6.  Metabolism of halofantrine to its equipotent metabolite, desbutylhalofantrine, is decreased when orally administered with ketoconazole.

Authors:  S M Khoo; J H Porter; G A Edwards; W N Charman
Journal:  J Pharm Sci       Date:  1998-12       Impact factor: 3.534

7.  Effect of polyoxyl 35 castor oil and Polysorbate 80 on the intestinal absorption of digoxin in vitro.

Authors:  G Cornaire; J F Woodley; S Saivin; J Y Legendre; S Decourt; A Cloarec; G Houin
Journal:  Arzneimittelforschung       Date:  2000-06

8.  Factors influencing triacylglycerol delivery into mesenteric lymph.

Authors:  C M Mansbach; A Arnold; M A Cox
Journal:  Am J Physiol       Date:  1985-11

Review 9.  Formation and transport of chylomicrons by enterocytes to the lymphatics.

Authors:  P Tso; J A Balint
Journal:  Am J Physiol       Date:  1986-06

10.  Reversal of multidrug resistance by surfactants.

Authors:  D M Woodcock; M E Linsenmeyer; G Chojnowski; A B Kriegler; V Nink; L K Webster; W H Sawyer
Journal:  Br J Cancer       Date:  1992-07       Impact factor: 7.640

View more
  7 in total

1.  Intestinal lymphatic transport enhances the post-prandial oral bioavailability of a novel cannabinoid receptor agonist via avoidance of first-pass metabolism.

Authors:  Natalie L Trevaskis; David M Shackleford; William N Charman; Glenn A Edwards; Anne Gardin; Silke Appel-Dingemanse; Olivier Kretz; Bruno Galli; Christopher J H Porter
Journal:  Pharm Res       Date:  2009-03-12       Impact factor: 4.200

2.  The Effect of Digestion and Drug Load on Halofantrine Absorption from Self-nanoemulsifying Drug Delivery System (SNEDDS).

Authors:  Maria Høtoft Michaelsen; Kishor M Wasan; Olena Sivak; Anette Müllertz; Thomas Rades
Journal:  AAPS J       Date:  2016-01       Impact factor: 4.009

3.  Development of self-nanoemulsifying drug delivery system for oral bioavailability enhancement of valsartan in beagle dogs.

Authors:  Zhenbao Li; Wenjuan Zhang; Yan Gao; Rongwu Xiang; Yan Liu; Mingming Hu; Mei Zhou; Xiaohong Liu; Yongjun Wang; Zhonggui He; Yinghua Sun; Jin Sun
Journal:  Drug Deliv Transl Res       Date:  2017-02       Impact factor: 4.617

4.  Enhanced solubility and oral bioavailability of γ-tocotrienol using a self-emulsifying drug delivery system (SEDDS).

Authors:  Saeed Alqahtani; Alaadin Alayoubi; Sami Nazzal; Paul W Sylvester; Amal Kaddoumi
Journal:  Lipids       Date:  2014-06-17       Impact factor: 1.880

5.  Clinical studies with oral lipid based formulations of poorly soluble compounds.

Authors:  Dimitrios G Fatouros; Ditte M Karpf; Flemming S Nielsen; Anette Mullertz
Journal:  Ther Clin Risk Manag       Date:  2007-08       Impact factor: 2.423

6.  Nonlinear absorption kinetics of self-emulsifying drug delivery systems (SEDDS) containing tocotrienols as lipophilic molecules: in vivo and in vitro studies.

Authors:  Saeed Alqahtani; Alaadin Alayoubi; Sami Nazzal; Paul W Sylvester; Amal Kaddoumi
Journal:  AAPS J       Date:  2013-04-10       Impact factor: 4.009

7.  Evaluation of Pharmacokinetics, and Bioavailability of Higher Doses of Tocotrienols in Healthy Fed Humans.

Authors:  Asaf A Qureshi; Dilshad A Khan; Neerupma Silswal; Shahid Saleem; Nilofer Qureshi
Journal:  J Clin Exp Cardiolog       Date:  2016-04-28
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.